BACKGROUND: The clinical epidemiology of group A streptococcal (GAS) infections in Hawaii seems different from that in the continental United States with frequent skin infections and endemically high rates of acute rheumatic fever (ARF). METHODS: GAS emm types in Hawaii were determined to identify any possible association between the emm types and specific clinical manifestations. A convenience sample of 1482 Hawaii GAS isolates collected between February 2000 and December 2005 was used. All isolates were characterized by emm sequence typing. The distribution of emm types in Hawaii was compared with the published continental US data for pharyngeal and invasive GAS strains, the CDC database from similar time periods, as well as with emm types present in a candidate GAS vaccine. RESULTS: Ninety-three distinct emm types were recognized among the 1482 GAS isolates. The most frequently identified emm types in order of decreasing frequency were 12, 1, 28, 4, 22, 77, 81, 58, 65/69, 49, 74, 85, 92, 75, 101 and 2. Of this study sample, 27 of the 50 invasive GAS isolates belonged to uncommon continental US emm types (54% in Hawaii cultures vs. 10% reported from the continental US). Of the 1179 pharyngeal isolates, 509 belonged uncommon continental US emm types (43% in Hawaii cultures vs. 27% reported from the continental US). CONCLUSIONS: The prevalent emm types in Hawaii differ from those in the continental US. The prevalence of these unusual emm types might limit the effectiveness of any proposed multivalent type-specific GAS vaccine in Hawaii.
BACKGROUND: The clinical epidemiology of group A streptococcal (GAS) infections in Hawaii seems different from that in the continental United States with frequent skin infections and endemically high rates of acute rheumatic fever (ARF). METHODS:GAS emm types in Hawaii were determined to identify any possible association between the emm types and specific clinical manifestations. A convenience sample of 1482 Hawaii GAS isolates collected between February 2000 and December 2005 was used. All isolates were characterized by emm sequence typing. The distribution of emm types in Hawaii was compared with the published continental US data for pharyngeal and invasive GAS strains, the CDC database from similar time periods, as well as with emm types present in a candidate GAS vaccine. RESULTS: Ninety-three distinct emm types were recognized among the 1482 GAS isolates. The most frequently identified emm types in order of decreasing frequency were 12, 1, 28, 4, 22, 77, 81, 58, 65/69, 49, 74, 85, 92, 75, 101 and 2. Of this study sample, 27 of the 50 invasive GAS isolates belonged to uncommon continental US emm types (54% in Hawaii cultures vs. 10% reported from the continental US). Of the 1179 pharyngeal isolates, 509 belonged uncommon continental US emm types (43% in Hawaii cultures vs. 27% reported from the continental US). CONCLUSIONS: The prevalent emm types in Hawaii differ from those in the continental US. The prevalence of these unusual emm types might limit the effectiveness of any proposed multivalent type-specific GAS vaccine in Hawaii.
Authors: Stanford T Shulman; Robert R Tanz; William Kabat; Kathleen Kabat; Emily Cederlund; Devendra Patel; Zhongya Li; Varja Sakota; James B Dale; Bernard Beall Journal: Clin Infect Dis Date: 2004-07-15 Impact factor: 9.079
Authors: Stanford T Shulman; Gene Stollerman; Bernard Beall; James B Dale; Robert R Tanz Journal: Clin Infect Dis Date: 2006-01-17 Impact factor: 9.079
Authors: Nancy P Hoe; Kathleen E Fullerton; Mengyao Liu; John E Peters; Gary D Gackstetter; Gerald J Adams; James M Musser Journal: J Infect Dis Date: 2003-09-04 Impact factor: 5.226
Authors: Karen L Kotloff; Mary Corretti; Kathleen Palmer; James D Campbell; Mark A Reddish; Mary C Hu; Steven S Wasserman; James B Dale Journal: JAMA Date: 2004-08-11 Impact factor: 56.272
Authors: S Le Hello; A Doloy; F Baumann; N Roques; P Coudene; B Rouchon; F Lacassin; A Bouvet Journal: J Clin Microbiol Date: 2009-12-02 Impact factor: 5.948
Authors: G Erdem; S Sinclair; J R Marrone; T F I'atala; A Tuua; B Tuua; F Tuumua; A Dodd; C Mizumoto; L Medina Journal: Clin Microbiol Infect Date: 2009-07-20 Impact factor: 8.067
Authors: Alan F Garcia; Lucienne M Abe; Guliz Erdem; Chari L Cortez; David Kurahara; Karen Yamaga Journal: Microbiology (Reading) Date: 2010-07-15 Impact factor: 2.777